We read with great interest the article by Arias-de la Rosa et al., published in the European Journal of Internal Medicine [1]. This study provides valuable evidence that patients with rheumatoid arthritis (RA), even in the absence of common comorbidities such as obesity and diabetes, may experience liver dysfunction driven by autoimmune mechanisms. However, several methodological aspects could be refined, offering avenues for further investigation.
